Cargando…
The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies”
Malignant melanoma is the most deadly form of skin cancer. It originates from melanocytic cells and can also arise at other body sites. Early diagnosis and appropriate medical care offer excellent prognosis with up to 5-year survival rate in more than 95% of all patients. However, long-term survival...
Autores principales: | Strub, Thomas, Ballotti, Robert, Bertolotto, Corine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993228/ https://www.ncbi.nlm.nih.gov/pubmed/32042336 http://dx.doi.org/10.7150/thno.36218 |
Ejemplares similares
-
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022) -
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
por: Ballotti, Robert, et al.
Publicado: (2020) -
An Update on the Role of Ubiquitination in Melanoma Development and Therapies
por: Soysouvanh, Frédéric, et al.
Publicado: (2021) -
Focus on cutaneous and uveal melanoma specificities
por: Pandiani, Charlotte, et al.
Publicado: (2017) -
Melanoma: From Melanocyte to Genetic Alterations and Clinical Options
por: Bertolotto, Corine
Publicado: (2013)